News
Caliway receives US FDA clearance to proceed with SUPREME-01 phase 3 study of CBL-514 for reducing abdominal subcutaneous fat: New Taipei City Tuesday, July 29, 2025, 14:00 Hrs [I ...
Experts say supplement companies have tried to capitalize on the GLP-1 craze, putting the phrase in their product names, ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Explore the potential of GLP-1 receptor agonists for rheumatoid arthritis. Learn about their safety, benefits, and what to consider before starting these medications.
There's been plenty of buzz about this class of drug, following publication of a high-profile trial this year. How much do we ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
Researchers found that tirzepatide, a medication primarily used for treating type 2 diabetes and weight loss, reduced body ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
GLP-1 drugs have been compared to the discovery of penicillin, which changed the course of medicine by treating several ...
Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, ...
New medicines have made weight loss easier than ever. But if you also want health and happiness, make these seven psychology ...
Q2 2025 has demonstrated the pharmaceutical industry’s continued momentum in developing transformative therapies across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results